QIAGEN N.V.

QGEN
Delayed Quote. Delayed  - 07/30 04:10:00 pm
52.79USD +1.09%

Turn to zoom
Prev.52.2200
Open53.6100
High54.0100
Low52.7100
Volume1 335 973
Latest news
1h ago
1h ago
1h ago
1h ago
Chart QIAGEN N.V.
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishNeutralNeutral
Resistance54,356,056,0
Spread/Res.-2,8%-5,8%-5,8%
Spread/Supp.6,9%14%13%
Support49,446,346,6
Financials
Sales 2021 2 136 M - -
Net income 2021 433 M - -
Net Debt 2021 727 M - -
P/E ratio 2021 26,7x
Yield 2021 -
Capitalization 12 062 M 12 062 M -
EV / Sales 2021 5,99x
EV / Sales 2022 6,20x
Nbr of Employees 5 961
Free-Float 98,2%
Company
QIAGEN N.V. (QIAGEN) is a holding company. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample...

>> Read more
Sector :
Other Biotechnology & Medical Research
Calendar :
2021-08-31 Presentation
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Mean consensus OUTPERFORM
Number of Analysts 14
Last Close Price 52,79 $
Average target price 53,88 $
Spread / Average Target 2,07%